Mastoid oscillation in canalith repositioning for paroxysmal positional vertigo

Eric W. Sargent, Aukse E. Bankaitis, Christopher S. Hollenbeak, John W. Currens

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Objective: The canalith repositioning procedure (CRP) was developed to treat paroxysmal positional vertigo (PPV). Successful CRP results in cessation of PPV and positional nystagmus. Mastoid oscillation (MO) has been advocated to enhance the efficacy of CRP. The authors sought to objectively determine the effect of MO on CRP. Study Design: Retrospective review. Setting: Ambulatory referral center. Patients: Patients with PPV seen from 1993 through 1999 (N = 168). Interventions: Canalith repositioning procedure performed without MO (n = 104) and performed with MO (n = 64). Main Outcome Measure: Presence or absence of nystagmus on Dix-Hallpike testing 6 weeks after CRP. Results: Eighty-four percent of patients treated with MO had resolution, and 16% had persistent nystagmus. Seventy-three percent of patients without MO had resolution, and 27% had persistent nystagmus. Although suggesting a trend, the difference did not reach the level of significance (p = 0.151). Conclusions: Mastoid oscillation does not significantly enhance the efficacy of the CRP.

Original languageEnglish (US)
Pages (from-to)205-209
Number of pages5
JournalOtology and Neurotology
Volume22
Issue number2
DOIs
StatePublished - Jan 1 2001

Fingerprint

Mastoid
Vertigo
Physiologic Nystagmus
Referral and Consultation
Retrospective Studies
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Otorhinolaryngology
  • Sensory Systems
  • Clinical Neurology

Cite this

Sargent, Eric W. ; Bankaitis, Aukse E. ; Hollenbeak, Christopher S. ; Currens, John W. / Mastoid oscillation in canalith repositioning for paroxysmal positional vertigo. In: Otology and Neurotology. 2001 ; Vol. 22, No. 2. pp. 205-209.
@article{784ea06c4eef405eb3d45c060fbe3b30,
title = "Mastoid oscillation in canalith repositioning for paroxysmal positional vertigo",
abstract = "Objective: The canalith repositioning procedure (CRP) was developed to treat paroxysmal positional vertigo (PPV). Successful CRP results in cessation of PPV and positional nystagmus. Mastoid oscillation (MO) has been advocated to enhance the efficacy of CRP. The authors sought to objectively determine the effect of MO on CRP. Study Design: Retrospective review. Setting: Ambulatory referral center. Patients: Patients with PPV seen from 1993 through 1999 (N = 168). Interventions: Canalith repositioning procedure performed without MO (n = 104) and performed with MO (n = 64). Main Outcome Measure: Presence or absence of nystagmus on Dix-Hallpike testing 6 weeks after CRP. Results: Eighty-four percent of patients treated with MO had resolution, and 16{\%} had persistent nystagmus. Seventy-three percent of patients without MO had resolution, and 27{\%} had persistent nystagmus. Although suggesting a trend, the difference did not reach the level of significance (p = 0.151). Conclusions: Mastoid oscillation does not significantly enhance the efficacy of the CRP.",
author = "Sargent, {Eric W.} and Bankaitis, {Aukse E.} and Hollenbeak, {Christopher S.} and Currens, {John W.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1097/00129492-200103000-00015",
language = "English (US)",
volume = "22",
pages = "205--209",
journal = "Otology and Neurotology",
issn = "1531-7129",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

Mastoid oscillation in canalith repositioning for paroxysmal positional vertigo. / Sargent, Eric W.; Bankaitis, Aukse E.; Hollenbeak, Christopher S.; Currens, John W.

In: Otology and Neurotology, Vol. 22, No. 2, 01.01.2001, p. 205-209.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Mastoid oscillation in canalith repositioning for paroxysmal positional vertigo

AU - Sargent, Eric W.

AU - Bankaitis, Aukse E.

AU - Hollenbeak, Christopher S.

AU - Currens, John W.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Objective: The canalith repositioning procedure (CRP) was developed to treat paroxysmal positional vertigo (PPV). Successful CRP results in cessation of PPV and positional nystagmus. Mastoid oscillation (MO) has been advocated to enhance the efficacy of CRP. The authors sought to objectively determine the effect of MO on CRP. Study Design: Retrospective review. Setting: Ambulatory referral center. Patients: Patients with PPV seen from 1993 through 1999 (N = 168). Interventions: Canalith repositioning procedure performed without MO (n = 104) and performed with MO (n = 64). Main Outcome Measure: Presence or absence of nystagmus on Dix-Hallpike testing 6 weeks after CRP. Results: Eighty-four percent of patients treated with MO had resolution, and 16% had persistent nystagmus. Seventy-three percent of patients without MO had resolution, and 27% had persistent nystagmus. Although suggesting a trend, the difference did not reach the level of significance (p = 0.151). Conclusions: Mastoid oscillation does not significantly enhance the efficacy of the CRP.

AB - Objective: The canalith repositioning procedure (CRP) was developed to treat paroxysmal positional vertigo (PPV). Successful CRP results in cessation of PPV and positional nystagmus. Mastoid oscillation (MO) has been advocated to enhance the efficacy of CRP. The authors sought to objectively determine the effect of MO on CRP. Study Design: Retrospective review. Setting: Ambulatory referral center. Patients: Patients with PPV seen from 1993 through 1999 (N = 168). Interventions: Canalith repositioning procedure performed without MO (n = 104) and performed with MO (n = 64). Main Outcome Measure: Presence or absence of nystagmus on Dix-Hallpike testing 6 weeks after CRP. Results: Eighty-four percent of patients treated with MO had resolution, and 16% had persistent nystagmus. Seventy-three percent of patients without MO had resolution, and 27% had persistent nystagmus. Although suggesting a trend, the difference did not reach the level of significance (p = 0.151). Conclusions: Mastoid oscillation does not significantly enhance the efficacy of the CRP.

UR - http://www.scopus.com/inward/record.url?scp=0035086334&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035086334&partnerID=8YFLogxK

U2 - 10.1097/00129492-200103000-00015

DO - 10.1097/00129492-200103000-00015

M3 - Review article

C2 - 11300270

AN - SCOPUS:0035086334

VL - 22

SP - 205

EP - 209

JO - Otology and Neurotology

JF - Otology and Neurotology

SN - 1531-7129

IS - 2

ER -